Shin Kawamata
Kobe, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Development of Automated Systems for Cell Therapy.
Journal: Advances in experimental medicine and biology
Published: October 24, 2025
Development of Animal Models for Preclinical Safety Studies.
Journal: Advances in experimental medicine and biology
Published: October 24, 2025
Cell and gene therapy approvals in Asia: regulatory landscape, access and affordability.
Journal: Cytotherapy
Published: July 02, 2025
Study on the Extrapolability of Current Tumorgenicity Test With Mice by Comparing the Syngeneic or Allogeneic Mouse Transplantation Model.
Journal: Stem cells translational medicine
Published: December 19, 2023
Considerations for the development of iPSC-derived cell therapies: a review of key challenges by the JSRM-ISCT iPSC Committee.
Journal: Cytotherapy
Published: November 19, 2023
Challenges in Global Access to CAR-T cells: an Asian Perspective.
Journal: Blood cell therapy
Published: July 14, 2023
A Novel Approach for Determining the Critical Quality Attributes of Mesenchymal Stem Cells by Specifying Cell Population With Replication Potential.
Journal: Stem cells translational medicine
Published: September 27, 2022
Self-organization, quality control, and preclinical studies of human iPSC-derived retinal sheets for tissue-transplantation therapy.
Journal: Communications biology
Published: August 23, 2022
Improving the differentiation potential of pluripotent stem cells by optimizing culture conditions.
Journal: Scientific reports
Published: May 31, 2022
Correlation Between Genetic Abnormalities in Induced Pluripotent Stem Cell-Derivatives and Abnormal Tissue Formation in Tumorigenicity Tests.
Journal: Stem cells translational medicine
Published: December 29, 2021
Data on long-term survival of the NOD/Shi-scid IL-2Rγnull (NOG) mouse in two facilities.
Journal: The Journal of toxicological sciences
Published: October 04, 2021
A phase I/IIa clinical trial of third-generation autologous chondrocyte implantation (IK-01) for focal cartilage injury of the knee.
Journal: Asia-Pacific journal of sports medicine, arthroscopy, rehabilitation and technology
Published: October 01, 2021
Last Updated: 09/26/2026